Correspondence 0001104659-23-044851 from Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO)
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: April 13, 2023 · CIK: 0001429260 · Accession: 0001104659-23-044851
AI Filing Summary & Sentiment
File numbers found in text: 333-269687
Show Raw Text
CORRESP
1
filename1.htm
April 13, 2023
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Fortress
Biotech, Inc.
Registration Statement on Form S-3
File No. 333-269687
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Fortress Biotech, Inc. (the “Company”) hereby requests that the
Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration
Statement on Form S-3 (the “Registration Statement”) so that the Registration Statement will be declared effective
as of 4:00 p.m. Eastern time, on April 13, 2023, or at such other time as the Company or its outside counsel, McGuireWoods
LLP, may request via a telephone call to the staff of the Commission.
Once the Registration Statement
has been declared effective, please orally confirm that event with Rakesh Gopalan of McGuireWoods LLP at (704) 343-2275.
Thank you for your assistance
in this matter.
Very truly yours,
/s/ David Jin
Name: David Jin
Title: Chief Financial Officer
cc (electronic):
Sam Berry, General Counsel
Rakesh Gopalan, McGuireWoods LLP